A pilot study of three potential vaccines for leprosy in Bombay
Int. j. lepr. other mycobact. dis
; 57(1): 33-37, Mar. 1989. tab
Artículo
en Inglés
| Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1226407
Biblioteca responsable:
BR191.1
Ubicación: [{"text": "Br191.1"}]
ABSTRACT
Three vaccines, BCG Glaxo alone (vaccine A), BCG Glaxo plus 10(7) killed Mycobacterium vaccae (vaccine B), and BCG Glaxo plus 10(7) killed M. leprae (vaccine C), were given to groups of selected children. The effects of these vaccines on subsequent quadruple skin testing 1-3 years after vaccination were compared. All three vaccines equally and significantly (p less than 0.00001) increased positivity to tuberculin, but only vaccine B was found to significantly enhance development of skin-test positivity to leprosin A (p less than 0.002). The data support the evidence previously obtained in rural Iran that the combination of BCG with killed M. vaccae is likely to be a better vaccine for leprosy than is BCG alone
Texto completo:
Disponible
Colección:
Bases de datos nacionales
/
Brasil
Contexto en salud:
Enfermedades Desatendidas
Problema de salud:
Lepra
/
Enfermedades Desatendidas
Base de datos:
HANSEN
/
Hanseníase
/
Sec. Est. Saúde SP
/
SESSP-ILSLACERVO
Asunto principal:
Lepra
/
Mycobacterium leprae
Límite:
Adolescente
/
Niño, preescolar
/
Humanos
Idioma:
Inglés
Revista:
Int. j. lepr. other mycobact. dis
Año:
1989
Tipo del documento:
Artículo
Institución/País de afiliación:
The Bombay Leprosy Project/IN
/
University College and Middlesex School/GB
